NRC Health Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31)
NRC Health (NRC) reported Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) of $373.00 thousand for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-07.
Discontinued › Expense Statement › Income Tax
us-gaap:TaxBenefitFromStockOptionsExercised1 · last filed 2012-11-07
- NRC Health tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $100.00K, a 203.03% increase year-over-year.
- NRC Health tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $60.00K, a 2900.00% increase year-over-year.
- NRC Health tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2012-03-31 was $213.00K, a 965.00% increase year-over-year.
- NRC Health tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2011-09-30 was $33.00K.
| Period end | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 3 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 6 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 9 month |
|---|---|---|---|
| 2012-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $160.00K derived: sum of 2 quarters · filed 2012-11-07 | $373.00K 10-Q · filed 2012-11-07 |
| 2012-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $273.00K 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $213.00K 10-Q · filed 2012-05-11 | ||
| 2011-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $35.00K derived: sum of 2 quarters · filed 2012-11-07 | $55.00K 10-Q · filed 2012-11-07 |
| 2011-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $22.00K 10-Q · filed 2012-08-10 | |
| 2011-03-31 | $20.00K 10-Q · filed 2012-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |